Suchergebnisse - "López, Pío"

PubPharm (23)

1

Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003) : 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial

enthalten in: The Lancet. Global health | 2024

von Tricou, V. | Yu, D. | Reynales, H. | +29

2

Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age : A phase 2 randomized, double-blind trial

enthalten in: Human vaccines & immunotherapeutics | 2023

von López, P. | López-Medina, E. | Sáez-Llorens, X. | +6

3

Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12-17 year-old adolescents

enthalten in: Human vaccines & immunotherapeutics | 2023

von Lopez, P. | Bravo, L. | Buntinx, E. | +14

4

Saroglitazar is noninferior to fenofibrate in reducing triglyceride levels in hypertriglyceridemic patients in a randomized clinical trial

enthalten in: Journal of lipid research | 2022

von Rodriguez-Gutierrez, R. | González, J. | Parmar, D. | +2

5

Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age : A phase 2 randomized, double-blind study

enthalten in: Vaccine | 2022

von Vesikari, T. | Saez-Llorens, X. | Blazevic, V. | +8

6

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019 : a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

enthalten in: Lancet (London, England) | 2022

von Bravo, L. | Smolenov, I. | Han, H. | +44

CommentIn: Lancet. 2022 Jan 29;399(10323):415-417. - PMID 35065704

7

Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 : A Randomized Clinical Trial

enthalten in: JAMA | 2021

von López-Medina, E. | López, P. | Hurtado, I. | +16

8

Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years : a randomised, placebo-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2020

von Biswal, S. | Borja-Tabora, C. | Martinez Vargas, L. | +67

CommentIn: Lancet. 2020 May 2;395(10234):1402-1404. - PMID 32197106

9

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

enthalten in: The New England journal of medicine | 2019

von Biswal, S. | Reynales, H. | Saez-Llorens, X. | +39

CommentIn: N Engl J Med. 2020 Apr 30;382(18):1769. - PMID 32348658

10

A Randomized Controlled Study of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine for Primary and Booster Vaccinations of Healthy Infants and Toddlers in Latin America

enthalten in: The Pediatric infectious disease journal | 2017

von López, P. | Arguedas Mohs, A. | Abdelnour Vásquez, A. | +6